Physician profile
Steven Klein
NPI 1508834227
$1,234.28
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $668 · 2020: $177 · 2022: $86.85 · 2023: $245 · 2024: $57.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $302.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $195.07 | 2019-2020 | |
| Gilead Sciences, INC. | $166.36 | 2022-2023 | |
| Glaxosmithkline, LLC. | $146.92 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $110.13 | 2019-2020 | |
| Amgen INC. | $84.81 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $58.59 | 2023-2024 | Xifaxan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $52.20 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $50.26 | 2019-2020 | |
| Genentech USA, INC. | $44.95 | 2019-2020 | |
| Abbvie INC. | $39.48 | 2023 | |
| Ferring Pharmaceuticals INC. | $33.13 | 2023 | Rebyota |
| Lilly USA, LLC | $31.48 | 2019-2024 | Omvoh |
| Novo Nordisk INC | $28.15 | 2019 | |
| Circassia INC. | $28.04 | 2019-2020 | |
| Radius Health, INC. | $27.95 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $22.70 | 2023 | Injectafer |
| Intercept Pharmaceuticals, INC. | $19.50 | 2022 | |
| Merck Sharp & Dohme LLC | $15.41 | 2019 | |
| Boston Scientific Corporation | $14.60 | 2022 | |
| Celgene Corporation | $14.57 | 2023 | Zeposia |
| Amarin Pharma, INC. | $14.11 | 2020 | |
| Astellas Pharma US INC | $14.09 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $10.91 | 2019 | |
| Eisai INC. | $10.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Klein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.